We bring together experts from across the world to discuss new and innovative applications of Droplet Digital PCR technology and how it is advancing and accelerating discovery. You can find out more about the Droplet Digital PCR systems here.
Early and sensitive detection of therapy associated BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia using Droplet Digital PCR
Dr. Csaba Bödör, Senior Research Fellow, Semmelweis University, 1st Department of Pathology and Experimental Cancer Research, Molecular Oncohematology Research Group
November 7, 2019, 2:30 pm GMT / 3:30 pm CET
This webinar will focus on clinical application of a sensitive droplet digital PCR based monitoring approach being developed by Molecular Oncohematology research group at Semmelweis University allowing for early detection of ibrutinib resistance associated BTK mutations with potential relevance in early prediction of impending relapse and therapy failure.
Clinical Application of Circulating Tumour DNA in Melanoma
Dr Rebecca Lee, Clinical lecturer in medical oncology at The University of Manchester and The Christie NHS Foundation Trust
October 10, 2019, 15:00 PM BST / 16:00 CEST
Circulating tumour DNA (ctDNA) can be used as a prognostic biomarker, to monitor tumour burden, assess therapy response, identify resistance mechanisms to treatment and characterise tumour heterogeneity/evolution.
Digital Droplet PCR for the Detection of Extracellular Vesicle (EV)-Derived Biomarkers
Davide Zocco, PhD, Head of R&D - Exosomics Siena S.p.a.
September 12, 2019, 4:00 pm BST / 5:00 pm CEST
In this webinar, we will explore advantages and challenges of detecting EV-derived biomarkers by digital droplet PCR. A novel workflow that combines enrichment of cancer EVs with an optimized ddPCR assay will be proposed to improve sensitivity and provide diagnostic benefit.
Detecting resistance against targeted cancer therapy using whole blood RNA with ddPCR
Dr Christof Winter, Institute of Clinical Chemistry and Pathobiochemistry, Klinikum rechts der Isar, Technical University of Munich
March 28, 2019, 3:00 pm GMT / 4:00 pm CET
Our first webinar will talk through how we can detect tumour RNA using a liquid profiling approach using droplet digital PCR to accurately predict which patients will not respond to anti-androgen treatment due to AR-V7 based resistance of their tumours.